如瑞迪博士 RDY 深沪

等待开盘 10-24 09:30:00 美东时间

14.62

-0.250

-1.68%

华盛通

立即下载

最高14.75
今开14.71
成交量 83.73万股
最低 14.575
昨收 14.87
总市值 121.64亿
52周最高 16.0985
市盈率 ^静 18.24
换手率 0.10%
52周最低 12.1885
委比 7.69%
总股本 8.32亿
历史最高 16.8205
量比 1.02
振幅 1.18%
历史最低 4.667
每手 1
风险率 0.79%

个股概要

财务分析

公司资料

分红派息

分时图
日k
周k
月k

相关新闻

Trump administration prepares probe targeting global drug pricing — FT

The Trump administration is preparing to launch a new investigation under Section 301 of the Trade Act of 1974 to determine whether U.S. trading partners are underpaying for prescription drugs, potent...

10-22 17:26
ReadyTech Reports Cyber Incident Affecting VETtrak Platform

ReadyTech Holdings Ltd. ( ($AU:RDY) ) has issued an announcement. ReadyTech Hol...

10-17 10:47
CYBERDYNE Selected for Ukraine Reconstruction Subsidy

The latest announcement is out from CYBERDYNE ( ($JP:7779) ). CYBERDYNE has bee...

10-07 12:22
Esperion, Dr. Reddy's Laboratories Reach Patent Dispute Settlement; Dr. Reddy's Agrees Not To Market NEXLETOL Or NEXLIZET In US Before 2040

ANN ARBOR, Mich., Oct. 03, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ:ESPR) today announced that it has entered into a settlement agreement with Dr. Reddy's Laboratories, Inc. and its affiliate Dr. Reddy's Laboratories

10-03 20:04
美股盘后 | 齐默巴奥米特控股涨3.96%，Sayona Mining Limited Unsponsored ADR涨2.81%

齐默巴奥米特控股涨3.96%；Sayona Mining Limited Unsponsored ADR涨2.81%；艺电涨2.67%

09-17 06:11
Dr. Reddy’s Launches Tegoprazan in India for Gastrointestinal Diseases

An update from Dr Reddy’s Laboratories ( ($RDY) ) is now available. On Septembe...

09-16 21:25
Dr. Reddy’s Laboratories Allots Equity Shares Under Employee Stock Option Scheme

Dr Reddy’s Laboratories ( ($RDY) ) has issued an update. On September 15, 2025,...

09-15 19:48
Dr. Reddy’s Laboratories Receives USFDA Observations Post-Inspection

Dr Reddy’s Laboratories ( ($RDY) ) has provided an announcement. On September 1...

09-15 18:28
Dr. Reddy’s Acquires STUGERON® Portfolio to Enhance CNS Offerings

The latest announcement is out from Dr Reddy’s Laboratories ( ($RDY) ). On Sept...

09-11 23:18
Dr. Reddy’s Faces Customs Penalty for Export Incentives

The latest announcement is out from Dr Reddy’s Laboratories ( ($RDY) ). On Sept...

09-05 01:47

派息除权日	每股总股息	派息日期
2025-07-25	0.07
2024-07-30	0.41	2024-07-30
2023-07-28	0.41	2023-07-28
2022-08-01	0.32	2022-08-01
2022-07-08	0.32	2022-07-08
2021-07-30	0.28	2021-07-30
2021-07-08	0.28	2021-07-08
2020-07-10	0.27	2020-07-10
2019-07-12	0.27	2019-07-12
2018-07-13	0.27	2018-08-09
2017-07-13	0.29	2017-08-10
2016-07-14	0.28	2016-08-09
2015-07-08	0.29	2015-08-17
2014-08-01	0.27	2014-08-15
2013-07-10	0.23	2013-08-15
2012-06-27	0.23	2012-08-06
2011-06-29	0.23	2011-08-11
2011-06-14	0.64	2011-06-23
2010-06-30	0.22	2010-08-17
2009-07-02	0.11	2009-08-12
2008-07-03	0.07	2008-08-18
2007-07-06	0.07	2007-08-10
2006-07-07	0.11	2006-08-21
2005-07-07	0.11	2005-08-16
2004-07-15	0.11	2004-08-24
2003-08-07	0.11	2003-10-02
2002-08-08	0.05	2002-09-30
2001-11-20	0.10	2001-12-13

公司名称	如瑞迪博士
行业分类	制药
业务描述	Dr. Reddy's Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. It operates through the following segments: Global Generics, Pharmaceutical Services and Active Ingredients, and Others. The Global Generics segment consists of manufacturing and marketing of prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name or as generic finished dosages with therapeutic equivalence to branded formulations. The Pharmaceutical Services and Active Ingredients segment focuses on manufacturing and marketing of active pharmaceutical ingredients and intermediates, also known as API, which are the principal ingredients for finished pharmaceutical products. The Others segment includes the operations of the subsidiary of the company. The company was founded by Kallam Anji Reddy on February 24, 1984 and is headquartered in Hyderabad, India.

如瑞迪博士 RDY 深 沪

14.62

个股概要

财务分析

公司资料

相关新闻

分红派息

相关新闻

公司简介

如瑞迪博士 RDY 深沪